Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Epizyme, Inc.

Clinical trials sponsored by Epizyme, Inc., explained in plain language.

Now part of Ipsen S.A. IPN EURONEXT PARIS

Biopharmaceutical company developing epigenetic therapies for cancer.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 4 Completed 1 Terminated 3

Cancer drug tazemetostat gets Long-Term safety check in rollover trial

Disease control Completed

This study offers continued access to tazemetostat for 58 people with various cancers who already benefited from the drug in earlier trials. The main goal is to monitor long-term safety and side effects. Participants must have shown clinical benefit from tazemetostat before joini…

Phase: PHASE1, PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:56 UTC